FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC

BSE26491.85568.8 (+2.19 %)

PREV CLOSE (Rs.) 25923.05

OPEN PRICE (Rs.) 26290.15

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 912

TODAY'S LOW / HIGH (Rs.)26045.00 26543.00

52 WK LOW / HIGH (Rs.)25350 35921.55

NSE26490.00575 (+2.22 %)

PREV CLOSE( Rs. ) 25915.00

OPEN PRICE (Rs.) 26415.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 26490.00 (1)

VOLUME 6360

TODAY'S LOW / HIGH(Rs.) 25990.00 26550.00

52 WK LOW / HIGH (Rs.)25350 37000

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

240.20

Dividend Yield(%)

1.79

TTM EPS (Rs.)

717.26

P/E Ratio

36.93

Book Value (Rs.)

2064.48

Face Value (Rs.)

MCap (Rs. in Mn)

562933.32

Price/Earning (TTM)

35.21

Price/Sales (TTM)

8.25

Price/Book (MRQ)

12.83

PAT Margin (%)

21.43

ROCE (%)

47.87

Incorporation Year : 22-08 1944

Management Info :

Munir Shaikh - Chairman Kartik Rajendran - Managing Director

Registered Office :

Address : Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone : 022-50461000 / 2000 / 67978888

Email : webmasterindia@abbott.com / investorrelations.india@abbott.com

Website : www.abbott.co.in

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

02Mar Abbott India inches up on inking pact
Abbott India is currently trading at Rs. 26598.50, up by 103.35 points o..

27Feb Abbott India inks pact with Novo Nordi
Abbott India has entered into strategic collaboration with Novo Nordisk..

13Feb Abbott India informs about press release
Abbott India has informed that it enclosed Newspaper Publication of the..

Financials

	QTR Dec 25	ANNUAL 25
Net Profit	3759.6	14144.4
Gross Profit	5089.8	18869.5
Operating Profit	5332.3	19701.8
Net Sales	17240.4	64091.5

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)

12604.90 (4.93%)

M.Cap (Rs. in Cr)16171.95

Sanofi Cons. Health (BSE)

4540.95 (5.75%)

M.Cap (Rs. in Cr)10458.09

Bharat Parenterals (BSE)

1045.00 (16.08%)

M.Cap (Rs. in Cr)720.21

Pfizer (BSE)

4851.90 (2.80%)

M.Cap (Rs. in Cr)22196.34

Shareholding Pattern

	PROMOTERS	74.99%
	NON-INSTITUTION	15.83%
	MUTUAL FUNDS/UTI	7.65%
	FI/BANKS/INSURANCE	1.08%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Aditya Birla SL Pha...

6.92

Samco Flexi Cap Fun...

4.57

SBI MNC Fund-Reg(IDCW)

4.52

NJ ELSS Tax Saver S...

4.11

SBI Innovative Oppo...

4.06

LIC MF Healthcare F...

3.94

PGIM India Healthca...

3.79

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

ABBOTT INDIA LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives